灯盏细辛的化学成分及其制剂的研究进展

被引:28
作者
夏靓
机构
[1] 浙江绿城心血管病医院
关键词
灯盏细辛; 化学成分; 制剂; 进展;
D O I
暂无
中图分类号
R284 [中药化学]; R283.6 [剂型];
学科分类号
100802 [中药炮制学]; 100804 [中药化学];
摘要
目的:为进一步研究灯盏细辛新制剂提供参考。方法:以"灯盏细辛""化学成分""制剂""吸收机制""Erigeron breviscapus""Chemical composition""Preparation""Absorption mechanism"等为关键词,组合检索2001年1月-2015年9月在Pub Med、Elsevier、Wiley-Blackwell、Springer Link、中国知网、万方、维普等数据库及google中有关灯盏细辛的化学成分及各成分治疗效果局限性、灯盏细辛口服制剂、新的制剂设计思路并进行分析。结果与结论:共查阅到相关文献120篇,其中有效文献43篇。灯盏细辛制剂的主要质控指标为野黄芩苷和总咖啡酸酯,均存在生物利用度低的问题,利用现代药物制剂新技术是提高生物利用度的关键。但采取的新技术如将磷脂复合物与自分散纳米胶束结合来提高脂溶性、细胞水平的自乳化给药系统等新思路都有一定的局限性,需再进一步通过对其释药特性、体内转运过程、吸收动力学、生物利用度和药效进行相关性的系统研究。
引用
收藏
页码:111 / 113
页数:3
相关论文
共 32 条
[1]
磷脂复合物及其自微乳给药系统的口服吸收机理研究 [D]. 
张琴 .
复旦大学,
2012
[2]
A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: in vitro characteristics and in vivo performance [J].
Zhang, Zhiwen ;
Huang, Yan ;
Gao, Fang ;
Gao, Zhiwei ;
Bu, Huihui ;
Gu, Wangwen ;
Li, Yaping .
NANOMEDICINE, 2011, 6 (08) :1365-1379
[3]
Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2) [J].
Hanke, Ulrike ;
May, Karen ;
Rozehnal, Veronika ;
Nagel, Stefan ;
Siegmund, Werner ;
Weitschies, Werner .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (02) :260-268
[4]
Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes [J].
Christiansen, Anne ;
Backensfeld, Thomas ;
Weitschies, Werner .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (02) :376-382
[5]
A novel size-tunable nanocarrier system for targeted anticancer drug delivery [J].
Li, Yuanpei ;
Xiao, Kai ;
Luo, Juntao ;
Lee, Joyce ;
Pan, Shirong ;
Lam, Kit S. .
JOURNAL OF CONTROLLED RELEASE, 2010, 144 (03) :314-323
[6]
Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.[J].Arik Dahan;Brady T. West;Gordon L. Amidon.European Journal of Pharmaceutical Sciences.2008, 2
[7]
Preparation; Characterization and Evaluation of Marsupsin–Phospholipid Complex.[J].Mukesh S. Sikarwar;Shalini Sharma;Amit K. Jain;S. D. Parial.AAPS PharmSciTech.2008, 1
[8]
Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods [J].
Li, Ying ;
Yang, Da-Jian ;
Chen, Shi-Lin ;
Chen, Si-Bao ;
Chan, Albert Sun-Chi .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :563-577
[9]
Application of TPGS in polymeric nanoparticulate drug delivery system.[J].L. Mu;P.H. Seow.Colloids and Surfaces B: Biointerfaces.2005, 1
[10]
Absorption and metabolism of polyphenols in the gut and impact on health [J].
Scalbert, A ;
Morand, C ;
Manach, C ;
Rémésy, C .
BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (06) :276-282